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INTRODUCTION
In 1948, my (RS) grandfather bought a car; a
Morris Minor. It was slow, cramped and unre-
liable. Yet, as his needs changed over the
years, he did not buy another car because ‘it
was too difﬁcult’ to decide. Today, he does
not own a car. He can use community trans-
port, Uber drivers and car sharing schemes.
Transport has evolved remarkably since 1948,
driven by technological innovation, but also
institutional innovation in how we mobilise
new technologies. Unlike transport, global
health governance has not seen such institu-
tional innovation, even though diseases have
globalised and health emergencies become
more complex.
Historically, global health governance has
rested with the WHO. Criticisms of WHO
have become frustratingly familiar—weak
internal coordination, cumbersome bureau-
cracy, political appointments and ineffective
leadership. The Ebola outbreak prompted
some to describe it as facing a ‘do or die’
moment.1
Despite the Director-General admitting
that ‘WHO was overwhelmed’2 by the out-
break, WHO has not ‘done’, in the sense of
fundamental reform to address criticisms,
but nor has it ‘died’. Although the global
health community widely accepts that WHO
is no longer ﬁt-for-purpose, the design and
creation of an alternative remain fraught
with difﬁcult questions requiring imagin-
ation, an agreed vision and political consen-
sus. In their absence, the tinkering continues
and, with a few exceptions,3 most commenta-
tors cling to renovation (‘reform’), rather
than innovation.
A ‘Maginot-line’ mentality?
The United Nations system is designed for a
world of ‘nation states’. However, globalisa-
tion creates new organising logics which
reshape human activity and social interaction
and erodes territorial boundaries. A world
economy dominated by transnational cor-
porations precipitates unprecedented ﬂows
of capital, goods and services worldwide, and
the rise of global communications, especially
social media, is redeﬁning our identities and
perceptions of the world.
In this ‘transboundary’ world, government
institutions based on discrete populations
located on ﬁxed territories are increasingly
out-of-step. National governments seeking to
manage domestic economies, for example,
have limited control over factors of produc-
tion and consumption within a world
economy; as the global ﬁnancial crisis high-
lighted. Similarly, the capacity of national
health systems to protect and promote the
health of their citizens is compromised by
population mobility.
This erosion of national autonomy coin-
cides with an increased need for collective
action to address transboundary risks.
Consider disease outbreaks. WHO’s capacity
to undertake disease surveillance, monitor-
ing and reporting has traditionally relied on
reports from member states. The revised
International Health Regulations (IHR)
extend data collection to non-governmental
sources. Nevertheless, information is received
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▸ Although the global health community widely
accepts that WHO, as currently configured, is no
longer fit-for-purpose, commentators cling to
renovation (‘reform’), rather than innovation, at
the expense of a global health governance
system that reflects the needs of a very changed
world.
▸ Collective action in a globalised world requires
institutions that look very different from what we
currently have. Rather than the renovation of
outdated institutional forms—which are closed,
territorially fixed and hierarchical—we need to
harness innovations such as social networks,
open-source systems and the sharing economy.
▸ One of the biggest forms of institutional innov-
ation more broadly is ‘network governance’, by
which collective action is achieved through inter-
connected institutions spanning government,
business and civil society.
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by WHO and acted on through intergovernmental chan-
nels, such as the World Health Assembly and WHO
country ofﬁces. As the Ebola outbreak highlighted, the
system remains vulnerable to limited capacity (<40% of
member states have implemented the IHR), unwilling-
ness to report outbreaks and lack of enforcement
mechanisms. This has prompted calls for further revi-
sion, or implementation through alternative channels,
such as the Global Health Security Agenda.4
There are many salutary lessons about failing to adapt
to change. One of the most vivid is the Maginot line.
After World War I, the French government developed a
system of concrete fortiﬁcations, obstacles and weapons
installations along its eastern border to slow an enemy
invasion and give time for the French army to mobilise.
By the 1930s, however, military technology and strategy
had moved on and Germany’s blitzkrieg tactic, with the
rapid use of aircraft and highly mobile forces, over-
whelmed French border defences. The country was con-
quered in just 6 weeks. Seventy years on, amid rapid
globalisation, are we guilty of a ‘Maginot-line mentality’?
Adaptation to change in health governance can be
seen in the emerging ecosystem of innovation to
improve health information systems. The Global Public
Health Intelligence Network, HealthMap, Google Flu
Trends and other ‘big’ data systems track and predict
global disease outbreaks using web-crawling methods.
Bluedot, for example, brings together geographic infor-
mation systems, spatial analytics, data visualisation and
computer science to complement expertise in clinical
infectious diseases, travel and tropical medicine, and
public health to develop new ways of modelling infec-
tious disease spread and impact. Bluedot achieves this by
analysing ‘big data’: 3 billion travellers on commercial
ﬂights; mobile human, animal and insect populations;
climate data from satellites and news and social media
reports of disease outbreaks. Bluedot’s innovation is not
being reliant on, and therefore constrained by, data pro-
vided or organised by country, but envisions the world as
a whole, using data conﬁgured to capture planetary pat-
terns and trends as the basis for collective action.5
Institutional innovation and networked governance
In business, a distinction is drawn between improvement
of existing products and processes, and innovation which
is ‘something truly different…that makes your custo-
mers’ lives better.6 Innovation thinking has recently
been extended to address social issues (‘social innov-
ation’) and ‘institutional innovation’, focusing on rede-
signing the roles, relationships and governance
structures required to bring participants together in pro-
ductive endeavours.
One of the major forms of institutional innovation is
‘network governance’, where collective action is
achieved through interconnected institutions spanning
government, business and civil society. Networks aim to
create synergies across different competencies and
expertise to deal with complex problems, including
mobilisation of resources and coproduction of policy
interventions. Critically, these networks are ﬂuid, with
different actors coming together and then disbanding,
to focus on issues of relevance to them. In global health,
although public–private partnerships bring together a
range of stakeholders like this, critics question how truly
‘open’ they are, and whether they remain too dominated
by powerful state and corporate interests.7–9
In contrast, crowdsourcing (obtaining services, ideas
or content by soliciting contributions from a large group
of people rather than traditional sources) is being used
by the Open Source Drug Discovery, launched in 2008,
to ﬁnd solutions for neglected diseases. This brings
together around 7500 researchers, students, industries,
educational institutions and others across 130 countries
to create new drugs in the public domain.10
Crowdsourcing is more participatory, iterative and inter-
active, which can also lead to ‘more efﬁcient surfacing
of problems’.11
There are opportunities for global health governance
to draw on such examples of institutional innovation.
For instance, the ‘sharing economy’, whereby people
worldwide rent accommodation, vehicles and other
major assets directly from each other via online transac-
tions, might help organise how we invest in, and then
share, major assets beneﬁting health across countries,
such as laboratories, computer technologies and data
sources. Innovations in political institutions and process
are also emerging, such as social media analytics and
cloud-based policymaking, which seek to open-up policy-
making in response to an increasingly complex and
fast-paced world.12 Existing global health governance
institutions have been slow to embrace these new ways of
being and doing. Built on traditional public administra-
tive models, they are increasingly obsolete and
out-of-step in a transboundary world.
Conclusion: from AIDS to Zika
Since the 1990s, WHO has undergone almost constant
reform under four director generals. All have sought to
revive the organisation’s leadership role in a world in
desperate need of effective global health governance.
None have succeeded. Meanwhile, global health has
faced a succession of diseases reﬂecting a globalising
world. The AIDS pandemic taught us that global solidar-
ity, not the marginalisation of people living with HIV, is
essential to effective prevention, control and treatment.
The SARS outbreak and inﬂuenza pandemics taught us
that all countries—rich or poor—are vulnerable to the
rapid global spread of disease. The Ebola outbreak
taught us that any weak links in a global system of
disease surveillance, monitoring and reporting poses
risks to us all. The Zika virus taught us that many dis-
eases are rapidly circulating the planet that pose health
risks which we know too little about. All teach us that
governments alone are unable to mobilise and deploy
sufﬁcient knowledge, human capital and other resources
in a timely manner.
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Rather than renovation of outmoded institutional
forms—which are closed, territorially ﬁxed and hierarch-
ical—we need to harness the power of networks, open
systems and other innovations that enable new forms of
collective action to achieve public goals. Human soci-
eties are rapidly evolving on a planetary scale. Many
argue that WHO was once the lead organisation and
can be again. Others ask, if not then what is the
alternative?13
WHO could potentially regain its leadership role by
embracing innovations that share ideas, resources and
authority more openly. But this will require it to enable
consensus on issues that transcend borders in a nimble
and timely manner.14 The real innovation, however, will
be in mechanisms to facilitate the formation of net-
works, sharing of resources, generation of ideas and
enabling of decision-making across constituencies that
are not conﬁned to states alone. The world now needs
institutions that bring together expertise and ideas from
far and wide, not ﬁxed, bureaucratic and hierarchical
structures which constrain how we deﬁne problems and
their solutions. No matter how much renovation is
undertaken, a car from 1948 will never meet modern
expectations. Like my grandfather today, we should
reﬂect on our needs, look at the options and be pre-
pared for a stark departure from how we have operated
thus far.
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